Log In
BCIQ
Print this Print this
 

NU 400 (NU400)

  Manage Alerts
Collapse Summary General Information
Company Nuron Biotech Inc.
DescriptionLong-acting version of recombinant human interferon beta-1b (NU 100) produced using PolyTherics TheraPEG technology
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat multiple sclerosis (MS)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/30/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today